TY - JOUR
T1 - Microglia and macrophages express tumor necrosis factor receptor p75 following middle cerebral artery occlusion in mice
AU - Lambertsen, K L
AU - Clausen, B H
AU - Fenger, C
AU - Wulf, H
AU - Owens, T
AU - Dagnaes-Hansen, F
AU - Meldgaard, M
AU - Finsen, B
PY - 2007/2/9
Y1 - 2007/2/9
N2 - The proinflammatory and potential neurotoxic cytokine tumor necrosis factor (TNF) is produced by activated CNS resident microglia and infiltrating blood-borne macrophages in infarct and peri-infarct areas following induction of focal cerebral ischemia. Here, we investigated the expression of the TNF receptors, TNF-p55R and TNF-p75R, from 1 to 10 days following permanent occlusion of the middle cerebral artery in mice. Using quantitative polymerase chain reaction (PCR), we observed that the relative level of TNF-p55R mRNA was significantly increased at 1-2 days and TNF-p75R mRNA was significantly increased at 1-10 days following arterial occlusion, reaching peak values at 5 days, when microglial-macrophage CD11b mRNA expression was also increased. In comparison, the relative level of TNF mRNA was significantly increased from 1 to 5 days, with peak levels 1 day after arterial occlusion. In situ hybridization revealed mRNA expression of both receptors in predominantly microglial- and macrophage-like cells in the peri-infarct and subsequently in the infarct, and being most marked from 1 to 5 days. Using green fluorescent protein-bone marrow chimeric mice, we confirmed that TNF-p75R was expressed in resident microglia and blood-borne macrophages located in the peri-infarct and infarct 1 and 5 days after arterial occlusion, which was supported by Western blotting. The data show that increased expression of the TNF-p75 receptor following induction of focal cerebral ischemia in mice can be attributed to expression in activated microglial cells and blood-borne macrophages.
AB - The proinflammatory and potential neurotoxic cytokine tumor necrosis factor (TNF) is produced by activated CNS resident microglia and infiltrating blood-borne macrophages in infarct and peri-infarct areas following induction of focal cerebral ischemia. Here, we investigated the expression of the TNF receptors, TNF-p55R and TNF-p75R, from 1 to 10 days following permanent occlusion of the middle cerebral artery in mice. Using quantitative polymerase chain reaction (PCR), we observed that the relative level of TNF-p55R mRNA was significantly increased at 1-2 days and TNF-p75R mRNA was significantly increased at 1-10 days following arterial occlusion, reaching peak values at 5 days, when microglial-macrophage CD11b mRNA expression was also increased. In comparison, the relative level of TNF mRNA was significantly increased from 1 to 5 days, with peak levels 1 day after arterial occlusion. In situ hybridization revealed mRNA expression of both receptors in predominantly microglial- and macrophage-like cells in the peri-infarct and subsequently in the infarct, and being most marked from 1 to 5 days. Using green fluorescent protein-bone marrow chimeric mice, we confirmed that TNF-p75R was expressed in resident microglia and blood-borne macrophages located in the peri-infarct and infarct 1 and 5 days after arterial occlusion, which was supported by Western blotting. The data show that increased expression of the TNF-p75 receptor following induction of focal cerebral ischemia in mice can be attributed to expression in activated microglial cells and blood-borne macrophages.
KW - Animals
KW - Brain/blood supply
KW - Brain Infarction/metabolism
KW - CD11 Antigens/genetics
KW - Cytokines/metabolism
KW - Gliosis/etiology
KW - Green Fluorescent Proteins
KW - Infarction, Middle Cerebral Artery/metabolism
KW - Macrophages/metabolism
KW - Male
KW - Mice
KW - Mice, Inbred C57BL
KW - Microglia/metabolism
KW - Middle Cerebral Artery/pathology
KW - RNA, Messenger/metabolism
KW - Receptors, Nerve Growth Factor/genetics
KW - Receptors, Tumor Necrosis Factor, Type I/genetics
KW - Signal Transduction/physiology
KW - Transplantation Chimera
KW - Tumor Necrosis Factor Decoy Receptors/genetics
KW - Tumor Necrosis Factor-alpha/metabolism
KW - Up-Regulation/physiology
U2 - 10.1016/j.neuroscience.2006.10.046
DO - 10.1016/j.neuroscience.2006.10.046
M3 - Article
C2 - 17161916
SN - 0306-4522
VL - 144
SP - 934
EP - 949
JO - Neuroscience
JF - Neuroscience
IS - 3
ER -